Applied DNA Sciences (NASDAQ:APDN – Get Free Report) posted its earnings results on Thursday. The technology company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $1.11, Zacks reports. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The company had revenue of $0.80 million for the quarter, compared to analyst estimates of $0.95 million. During the same quarter in the previous year, the firm earned ($4.80) earnings per share.
Applied DNA Sciences Trading Up 2.9 %
Shares of APDN stock traded up $0.01 during trading hours on Friday, reaching $0.36. 424,759 shares of the company’s stock were exchanged, compared to its average volume of 492,432. The stock’s fifty day moving average price is $0.44 and its two-hundred day moving average price is $5.39. The stock has a market cap of $354,600.00, a PE ratio of -0.02 and a beta of 0.09. Applied DNA Sciences has a 1 year low of $0.33 and a 1 year high of $35.90.
Analyst Upgrades and Downgrades
APDN has been the topic of a number of research analyst reports. HC Wainwright dropped their price target on Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating on the stock in a research note on Monday, June 10th. StockNews.com initiated coverage on Applied DNA Sciences in a research note on Thursday. They set a “sell” rating on the stock.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- What is the FTSE 100 index?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 8/5 – 8/9
- What is the S&P 500 and How It is Distinct from Other Indexes
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.